Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Terminated 2 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Lymphatic Metastasis 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Giant Cell Tumor of Bone 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Solid Tumor 1 Sarcoma, Ewing 1 Right Hemicolectomy 1 Rhabdomyosarcoma 1 Osteosarcoma 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Melanoma 1 Margins of Excision 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Giant Cell Tumor of Tendon Sheath 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Breast Cancer Lymphedema 1

Interventions

pembrolizumab 25 Paclitaxel 20 Carboplatin 17 Bevacizumab 12 Specimen Handling 10 Letrozole 10 abemaciclib 7 dostarlimab 6 Taxes 6 Blood Specimen Collection 6 Medroxyprogesterone Acetate 5 Magnetic Resonance Spectroscopy 5 Fulvestrant 5 Drug Therapy 5 Doxorubicin 5 Cisplatin 5 Biopsy 5 olaparib 4 lenvatinib 4 atezolizumab 4 Radiotherapy 4 Progestins 4 Observation 4 Nivolumab 4 Megestrol Acetate 4 Immunoglobulin G 4 Gemcitabine 4 trastuzumab deruxtecan 3 palbociclib 3 X-Rays 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × Indocyanine Green × Clear all

NCT04845828 2022-02-21

SELYE

Asan Medical Center

Phase NA Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡